FDAnews
www.fdanews.com/articles/120459-merck-says-eu-commission-approved-expanded-use-of-hiv-drug

Merck Says EU Commission Approved Expanded Use of HIV Drug

September 15, 2009
Merck Sharp & Dohme Limited announced that Isentress (raltegravir) has been granted an expanded licence from the European Union Commission for use in combination with other antiretroviral or ARV medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.
RTTNews